Protokinetix, Inc. 是一家处于研发阶段的生物技术公司,致力于抗衰老糖蛋白的医学科学研究。公司总部位于俄亥俄州戴尔顿。该公司于2002年1月7日上市。公司专注于抗冻糖蛋白(AFGPs)或抗衰老糖蛋白的医学科学研究。其抗衰老糖肽应用于眼科、皮肤科、器官移植支持和生物制造领域。AAGPs的商业应用包括多种医疗保健解决方案。该公司尚未开发出具有商业可行性的产品,也未产生任何收入。
PKTX stock price ended at $0.01 on 星期五, after rising 0.00%
On the latest trading day Apr 24, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 5.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 31.7K shares were traded, equating to a market value of approximately $3.9M.